Clinical research progress of long-term complications after treatment of Hodgkin lymphoma / 白血病·淋巴瘤

ABSTRACT

Hodgkin lymphoma (HL) is a malignant tumor which mainly occurs in young patients. With the improvement of clinical diagnosis and treatment, HL has become one of the highly curable malignant tumors, and the 5-year survival rate was over 80%. However, both expected survival time and quality of life of HL survivors are affected by long-term complications after treatment. This article reviews the clinical research progress of HL common long-term complications and puts forward the suggestions for the whole-process management of HL long-term complications in combination with relevant guidelines.